AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 285: H1206-H1212, 2003. First published May 8, 2003; doi:10.1152/ajpheart.00085.2003
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/3/H1206    most recent
00085.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Zander, K.
Right arrow Articles by de Leeuw, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Zander, K.
Right arrow Articles by de Leeuw, P. W.

Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study

Kim van der Zander,1 Alphons J. H. M. Houben,1 Leo Hofstra,2 Abraham A. Kroon,1 and Peter W. de Leeuw1

Departments of 1Medicine and 2Cardiology, Cardiovascular Research Institute Maastricht, and University Hospital, 6202 AZ Maastricht, The Netherlands

Submitted 30 January 2003 ; accepted in final form 29 April 2003

Brain natriuretic peptide (BNP) is a cardiac hormone with natriuretic activity. The aim of this study was to investigate the cardiovascular effects of pathophysiological levels of BNP on central hemodynamics, cardiac function, renal hemodynamics and function, and microvascular hemodynamics in healthy subjects. In this double-blind, placebo-controlled crossover study, we intravenously infused BNP (4 pmol · kg1 · min1) or placebo for 1 h on two separate days in 12 healthy subjects (mean age, 60 ± 5 yr). Nailfold and conjunctival capillary density, finger-skin (thermoregulatory) microvascular blood flow, and cardiac output were studied before and after infusion using intravital videomicroscopy, laser-Doppler fluxmetry, and echocardiography, respectively. Furthermore, during infusion, we measured the effective renal plasma flow and glomerular filtration rate using p-aminohippurate and inulin clearances. Blood pressure and heart rate were monitored for all measurements. Compared with placebo, BNP significantly decreased stroke volume with a tendency to decrease cardiac output. With subjects in the sitting position, mean arterial pressure decreased and heart rate increased after BNP infusion, whereas with subjects in the supine position, these variables remained unchanged. BNP increased natriuresis, diuresis, glomerular filtration rate, filtration fraction, and filtered load of Na+ compared with placebo, whereas effective renal plasma flow did not change. BNP did not affect the microvascular capillary density of conjunctiva and skin, microvascular blood flow, total skin oxygen capacity, and postocclusive recruitment. These results suggest that BNP has predominantly central and renal hemodynamic effects; however, it does not influence peripheral microcirculation in skin and conjunctiva.

microcirculation; function; blood pressure; heart rate; variability



Address for reprint requests and other correspondence: P. W. de Leeuw, Univ. Hospital Maastricht, Dept. of Internal Medicine, PO Box 5800, 6202 AZ Maastricht, The Netherlands (E-mail: p.deleeuw{at}intmed.unimaas.nl).




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. George, B. Morrow, K. Xu, G.-H. Yi, J. Holmes, E. X. Wu, Z. Li, A. A. Protter, M. C. Oz, and J. Wang
Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H708 - H717.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
V. Mitrovic, P. M. Seferovic, D. Simeunovic, A. D. Ristic, M. Miric, V. S. Moiseyev, Z. Kobalava, K. Nitsche, W.-G. Forssmann, H. Luss, et al.
Haemodynamic and clinical effects of ularitide in decompensated heart failure
Eur. Heart J., December 1, 2006; 27(23): 2823 - 2832.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
T. W. Vogelsang, C. C. Yoshiga, M. Hojgaard, A. Kjaer, J. Warberg, N. H. Secher, and S. Volianitis
The plasma atrial natriuretic peptide response to arm and leg exercise in humans: effect of posture
Exp Physiol, July 1, 2006; 91(4): 765 - 771.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.